Skip to contentFrançais

Is My MP a Landlord?

Rachel Bendayan

Liberal

Outremont

Quebec

  • Rachel Bendayan is not known to be a landlord
  • Rachel Bendayan holds significant investments

Gifts

Gift (Act) Received 2023/05/18

Nature

Admission to the C2MTL conference

Source

C2 International

Circumstances

As parliamentary secretary, accompanying Minister Boissonault on a Montreal tour

Liabilities

- Mortgage with Caisse Desjardins, joint with spouse

- Mortgage with TD Canada Trust, joint with spouse

Spouse's/Common-Law Partner's activities

- President and CEO of I-MED Pharma Inc.

- Board member and Secretary of JEM Workshop

- Director of 9033483 Canada Inc.

- Board member of 8679410 Canada Inc.

- Board member of AI4Eyes Medical Technologies

Spouse's/Common-Law Partner's investment in private corporations

- Joint ownership with another person of 90984394 Quebec Inc., a real estate holding company in Dollard-des-Ormeaux, Quebec

- Significant interest in 9033483 Canada Inc., a medical business located in Saint-Laurent, Quebec

Spouse's/Common-Law Partner's liabilities

- Guarantor of a loan with Scotiabank for I-MED Pharma Inc.

Spouse's/Common-Law Partner's source(s) of income

Last and next 12 months:

- Employment income from I-Med Pharma Inc.

Summary Statement

Obligation to provide a confidential report has been met and all initial reporting and compliance measures have been taken to comply with the Conflict of Interest Act.

Rachel Bendayan VS Average MP Contract Spending

(April 1, 2024 - March 31, 2025)

Rachel Bendayan is in the upper 75% of MP Contract Spending.

Top 5 Contract Expense Categories by Total Spend

(April 1, 2024 - March 31, 2025)

1. 🔴 Office Rental: $60,375
2. 🔵 Advertising: $39,472.08
3. 🟡 Research Consultants: $12,000
4. 🟠 Canadian Pins and Flags: $5,330.25
5. 🟣 Gifts given as a matter of protocol: $3,596.75
🟢 All Other Expenses: $26,658.01

Top 5 Sources Paid by Total Spending

(April 1, 2024 - March 31, 2025)

Top 5 Largest Individual Line Items

(April 1, 2024 - March 31, 2025)